Intervention Review

You have free access to this content

Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults

  1. Mattias Linde1,2,*,
  2. Wim M Mulleners3,
  3. Edward P Chronicle4,
  4. Douglas C McCrory5,6

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 24 JUN 2013

Assessed as up-to-date: 15 JAN 2013

DOI: 10.1002/14651858.CD010608


How to Cite

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010608. DOI: 10.1002/14651858.CD010608.

Author Information

  1. 1

    Norwegian University of Science and Technology, Department of Neuroscience, Trondheim, Norway

  2. 2

    St. Olav’s University Hospital, Norwegian Advisory Unit on Headaches, Trondheim, Norway

  3. 3

    Canisius Wilhelmina Ziekenhuis, Department of Neurology, Nijmegen, Netherlands

  4. 4

    University of Hawaii at Manoa, (Deceased) Department of Psychology, Manoa, USA

  5. 5

    Duke University Medical Center, Department of Medicine, Durham, NC, USA

  6. 6

    Durham Veterans Affairs Medical Center, Center for Health Services Research in Primary Care, Durham, NC, USA

*Mattias Linde, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. mattias.linde@ntnu.no.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 24 JUN 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Cady 2009 {published data only (unpublished sought but not used)}
de Tommaso 2007 {published and unpublished data}
  • de Tommaso M, Guido M, Sardaro M, Serpino C, Vecchio E, De Stefano G, et al. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neuroscience Letters 2008;442(2):81-5. [MEDLINE: 18620023]
  • de Tommaso M, Marinazzo D, Nitti L, Pellicoro M, Guido M, Serpino C, et al. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. Clinical Neurophysiology 2007;118(10):2297-304. [MEDLINE: 17709295]
Ghose 2002 {published data only}
  • Ghose K, Niven BE, Berry D. A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache. Journal of Headache & Pain 2002;3(2):79-85.
Gupta 2007 {published data only}
Mohammadianinejad 2011 {published data only (unpublished sought but not used)}
  • Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, et al. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Clinical Neuropharmacology 2011;34(4):174-7. [MEDLINE: 21738025]
Rompel 1970 {published data only}
  • Rompel H, Bauermeister PW. Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study. South African Medical Journal 1970;44(4):75-80. [MEDLINE: 4905910]
Silberstein 2008 {published data only (unpublished sought but not used)}
Steiner 1997 {published data only}
Stensrud 1979 {published data only}
Vahedi 2002 {published data only}
  • Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V, et al. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomized placebo-controlled trial. Journal of Neurology 2002;249(2):206-11. [MEDLINE: 11985388]

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Anthony 1972 {published data only}
  • Anthony M, Lance JW, Somerville B. A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine. Medical Journal of Australia 1972;1(26):1343-6. [MEDLINE: 4404482]
Chen 2001 {published data only}
Cochran 2004 {published data only}
D'Andrea 1999 {published data only}
Delvaux 2001 {published data only}
Hedri 1975 {published data only}
  • Hedri A. Rivotril in migraine [Rivotril bei Migräne]. Schweizerische Rundschau für Medizin Praxis 1975;64(33):1062-3. [MEDLINE: 1161753]
Lampl 1999 {published data only}
Skupin 1975 {published data only}
  • Skupin G, Franzke HG. The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychovegetative syndromes [Die Stellung von Dikalium-chlorazepat (Tranxilium) in der Therapie psychovegetativer Syndrome]. Medizinische Klinik 1975;70(31):1279-83. [MEDLINE: 54867]
Smirne 1979 {published data only}
  • Smirne S, Sinatra MG. Clonazepam in painful syndromes of the head [Il clonazepam nelle sindromi dolorose del distretto cefalico]. Rivista di Neurologia 1979;49(2):140-50. [MEDLINE: 451405]
Stieg 1977 {published data only}
Voto Bernales 1974 {published data only}
  • Voto Bernales J, Cruz G. Treatment of dysrhythmic migraines and other headaches with RO- 5-4023 [Tratamiento de la jaqueca distitmica y otras cefaleas con RO 5-4023]. Revista de Neuro-Psiquiatria 1974;37(1):1-8. [MEDLINE: 4453755]

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Ad Hoc Cttee 1962
  • Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717-8.
Alderson 2004
  • Alderson P, Green S, Higgins JPT, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Appendix 5b. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
Clarke 1996
Dalkara 2012
  • Dalkara S, Karakurt A. Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders. Current Topics in Medicinal Chemistry 2012;12(9):1033-71. [MEDLINE: 22352861]
Edmeads 1993
  • Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Canadian Journal of Neurological Sciences 1993;20(2):131-7. [MEDLINE: 8334575]
Edvinsson 2010
Evers 2009
GBD 2010 Study
  • Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380(9859):2163-96. [MEDLINE: 23245607]
Hollis 1999
ICHD-II 2004
  • Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:1-160.
IHS Cttee 1988
  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
Jadad 1996
Linde 2012
Linde 2013a
  • Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010610]
Linde 2013b
Linde 2013c
  • Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010609]
Linde 2013d
  • Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010608]
McQuay 1998
  • McQuay H, Moore R. An Evidence-based Resource for Pain Relief. Oxford: Oxford University Press, 1998.
Mehuys 2012
Olesen 2006
Porter 1992
  • Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG editor(s). Basic and Clinical Pharmacology. 5th Edition. Norwalk, CT: Appleton & Lange, 1992:331-49.
Silberstein 2012
  • Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E, Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78(17):1337-45. [MEDLINE: 22529202]
Tfelt-Hansen 2012
  • Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D'Amico D, Diener HC, et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia 2012;32(1):6-38. [MEDLINE: 22384463]
Victor 2003
Wiffen 2010

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Chronicle 2004
Mulleners 2008